Logo-apb
Adv Pharm Bull. 2022;12(3): 476-489. doi: 10.34172/apb.2022.051
PMID: 35935042        PMCID: PMC9348524

Review Article

CAR T Cells: Cancer Cell Surface Receptors Are the Target for Cancer Therapy

Behrouz Shademan 1 ORCID, Vahidreza Karamad 1, Alireza Nourazarian 2, Cigir Biray Avcı 1 * ORCID

Cited by CrossRef: 1


1- Mohaghegh N, Ahari A, Zehtabi F, Buttles C, Davani S, Hoang H, Tseng K, Zamanian B, Khosravi S, Daniali A, Kouchehbaghi N, Thomas I, Serati Nouri H, Khorsandi D, Abbasgholizadeh R, Akbari M, Patil R, Kang H, Jucaud V, Khademhosseini A, Hassani Najafabadi A. Injectable hydrogels for personalized cancer immunotherapies. Acta Biomaterialia. 2023;172:67 [Crossref]
2- Shademan B, Masjedi S, Karamad V, Isazadeh A, Sogutlu F, rad M, Nourazarian A. CRISPR Technology in Cancer Diagnosis and Treatment: Opportunities and Challenges. Biochem Genet. 2022;60(5):1446 [Crossref]